Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue

Histopathology

Volumn 61, Issue 6, 2012, Pages 1065-1071

  Hirota, Kyoko ^a   Wakisaka, Naohiro ^a   Sawada Kitamura, Seiko ^a   Kondo, Satoru ^a   Endo, Kazuhira ^a   Tsuji, Akira ^a   Murono, Shigeyuki ^a   Yoshizaki, Tomokazu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Intranodal lymphangiogenesis; Nodal recurrence; Squamous cell carcinoma of the tongue; Vascular endothelial growth factor C; Vascular endothelial growth factor D

Indexed keywords

PODOPLANIN; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MALE; NECK DISSECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE TONGUE; SURVIVAL RATE; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 84870389963     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04341.x     Document Type: Article

References (28)

1. Ho CM, Lam KH, Wei WI, Lau SK, Lam LK. Occult lymph node metastasis in small oral tongue cancers. Head Neck 1992; 14; 359-363.
2. Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A. Elective neck treatment versus observation in patients with T1/T2N0 squamous cell carcinoma of oral tongue. Oral Oncol. 2006; 42; 96-101.
3. Maekawa K, Sato H, Furukawa M, Yoshizaki T. Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model. Clin. Exp. Metastasis 2002; 19; 513-518.
4. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer 2001; 95; 44-50.
5. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metast. Rev. 2007; 26; 645-662.
6. Lee JG, Litton WB. Occult regional metastasis: carcinoma of the oral tongue. Laryngoscope 1972; 82; 1273-1281.
7. DiTroia JF. Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol. Clin. North Am. 1972; 5; 333-342.
8. Civantos FJ, Stoeckli SJ, Takes RP et al. What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?Eur. Arch. Otorhinolaryngol. 2010; 267; 839-844.
9. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009; 21; 154-165.
10. Bono P, Wasenius VM, Heikkila P, Lundin J, Jackson DG, Joensuu H. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin. Cancer Res. 2004; 10; 7144-7149.
11. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 2007; 170; 774-786.
12. Nakamura Y, Yasuoka H, Tsujimoto M et al. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res. Treat. 2005; 91; 125-132.
13. Van der Auwera I, Cao Y, Tille JC et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br. J. Cancer 2006; 95; 1611-1625.
14. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 2005; 201; 1089-1099.
15. Qian CN, Berghuis B, Tsarfaty G et al. Preparing the 'soil': the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006; 66; 10365-10376.
16. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9; 669-676.
17. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001; 7; 192-198.
18. Stacker SA, Caesar C, Baldwin ME et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001; 7; 186-191.
19. He Y, Kozaki K, Karpanen T et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl Cancer Inst. 2002; 94; 819-825.
20. Krishnan J, Kirkin V, Steffen A et al. Differential invivo and invitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 2003; 63; 713-722.
21. Liu B, Ma J, Wang X et al. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Anat. Rec. (Hoboken) 2008; 291; 1227-1235.
22. Nakamura Y, Yasuoka H, Tsujimoto M et al. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin. Cancer Res. 2003; 9; 716-721.
23. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 2004; 95; 32-39.
24. Sobin LH, Wittekind Ch. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002; 22-26.
25. Wakisaka N, Hirota K, Kondo S et al. Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma. Oral Oncol. In press.
26. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007; 109; 1010-1017.
27. Ueda A, Matsumoto T, Komuro Y. Lymphangiogenesis is a predictor of nodal metastasis in extramammary Paget's disease. Histopathology 2011; 58; 870-874.
28. Van den Eynden GG, Vandenberghe MK, van Dam PJ et al. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin. Cancer Res. 2007; 13; 5391-5397.